Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment

The American Journal of Medicine

Volumn 88, Issue 4, 1990, Pages 396-404

  Panos, Ralph J ^a   Mortenson, Rebecca L ^a   Niccoli, S Arlene ^a   King Jr , Talmadge E ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; FATALITY; HEART FAILURE; HUMAN; LUNG FIBROSIS; LUNG INSUFFICIENCY; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HUMAN; LUNG DISEASES; PULMONARY FIBROSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025248164     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(90)90495-Y     Document Type: Article

References (76)

1. Interstitial lung diseases of unknown cause
2. Interstitial lung diseases of unknown cause
3. Idiopathic pulmonary fibrosis
4. Interstitial lung disease: current concepts of pathogenesis, staging and therapy
5. Idiopathic pulmonary fibrosis
6. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects
7. Natural and treated course of usual and desquamative interstitial pneumonia
8. Diffuse interstitial pulmonary fibrosis: a clinical, radiological, and pathological study based on 45 patients
9. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
10. The prognosis of cryptogenic fibrosing alveolitis
11. Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednisone/azathioprine
12. Prognosis of cryptogenic fibrosing alveolitis
13. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features
14. Pulmonary heart disease: relation of pulmonary hypertension to abnormal lung structure and function
15. Pulmonary hypertension in the interstitial lung diseases
16. Clinical aspects of idiopathic pulmonary fibrosis
17. Correlative studies of pulmonary hypertension in idiopathic pulmonary fibrosis
18. Idiopathic pulmonary fibrosis
19. Cardiovascular function in cor pulmonale
20. Cryptogenic fibrosing alveolitis and lung cancer
21. Another presentation of fibrosing alveolitis and alveolar cell carcinoma
22. Alveolar cell carcinoma occurring in idiopathic interstitial pulmonary fibrosis
23. Simultaneous occurrence of pulmonary interstitial fibrosis and alveolar cell carcinoma in one family
24. Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer
25. Hypercoagulability of the blood associated with ACTH and cortisone therapy
26. Effect of prednisolone on the coagulation and fibrinolytic systems
27. Thromboembolic complications associated with ACTH and cortisone therapy
28. Distribution of ventilation-perfusion ratios in patients with interstitial lung disease
29. Interstitial pulmonary fibrosis: clinical features, natural history, and complications
30. Glucocorticosteroid therapy: mechanisms of action and clinical considerations
31. Increased incidence of pulmonary tuberculosis in chronic interstitial lung disease
32. Relief of breathlessness in a case of progressive pulmonary fibrosis
33. Familial chronic interstitial pneumonia
34. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis
35. Desquamative interstitial pneumonia
36. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of adrenocorticol steroid biosynthesis
37. Antiproliferative agents and drugs used for immunosuppression
38. Corticosteroids
39. Effect of corticosteroid treatment on respiratory muscle function and biochemical changes in the diaphragm
40. Decrease of respiratory muscle strength and static lung volumes in obese asthmatics
41. Fulminating diffuse interstitial fibrosis of the lungs
42. Desquamative interstitial pneumonia
43. Desquamative interstitial pneumonia: relationship to interstitial fibrosis
44. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs)
45. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases
46. Bronchial brushings and bronchial biopsy: comparison of diagnostic accuracy and cell typing reliability in lung cancer
47. Diagnostic accuracy in lung cancer: comparison of techniques used in association with flexible fiberoptic bronchoscopy
48. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host
49. Diagnostic fiberoptic bronchoscopy in the immunocompromised host with pulmonary infiltrates
50. The chest x-ray in idiopathic pulmonary fibrosis
51. Normal chest roentgenograms in chronic diffuse infiltrative lung disease
52. Fibrosing alveolitis: CT-pathologic correlation
53. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation
54. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography
55. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis
56. Clinical significance of pulmonary function tests in interstitial pulmonary disease
57. Radiographic-physiologic-pathologic correlations in interstitial pneumonias
58. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis
59. Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease
60. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy
61. Brochoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy
62. The immunology of cryptogenic fibrosing alveolitis (idiopathic pulmonary fibrosis)
63. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis
64. Prognostic role of eosinophils in pulmonary fibrosis
65. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphologic features and bronchoalveolar lavage
66. The role of gallium lung scanning in the evaluation of idiopathic pulmonary fibrosis
67. Circulating immune complexes in the idiopathic interstitial pneumonias
68. Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis
69. Serologic factors in idiopathic diffuse interstitial pulmonary fibrosis
70. Antibodies in some chronic fibrosing lung diseases I. Non organ-specific autoantibodies
71. Clinical significance of circulating immune complexes in “lone” cryptogenic fibrosing alveolitis and those with associated connective tissue disorders
72. Immune complexes, gallium lung scans, and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis, a structure-function clinical study
73. Measures of the inflammatory response in cryptogenic fibrosing alveolitis
74. Measurements of pulmonary glucose metabolism in patients with cryptogenic fibrosing alveolitis and pulmonary sarcoidosis
75. Accelerated clearance of small solutes from the lungs in interstitial lung disease